retatrutide phase 2 nejm 2023 obesity trial jastreboff Meets Weight Loss Endpoints in 3 Retatrutide Statistics 2026: Phase 2

Additional research confirms that semaglutide's benefit extends beyond simple calorie restriction

The doctor is looking at blood work, looking at your gut biome testing, looking at your DNA, and then saying, this is the right set of additives for you to have the best outcome

Avoid taking probiotics with hot food, beverages, or within 2 hours of antibiotics, which can kill the live cultures

Over a 3-year follow-up, the SURMOUNT-1 trial found that treatment with tirzepatide (a dual GLP1/GIP agonist) of patients with obesity and prediabetes led to substantial and sustained weight reduction, with a lower risk of progression to type 2 diabetes